PUBLIC CONTRACT · 2020
Aprov-Prt-20000109 (AP 2235)
- Contract value
- €12,589.20
- Signed on
- 10 March 2020
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 6416639PUBLISHED SUBJECT
AP 2235 - Aquisição de Medicamentos
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal; Portugal, Distrito não determinado, Concelho não determinado; Portugal, Porto, Maia; Portugal, Vila Real, Vila Real
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- GENERIS - FARMACEUTICA SA · Tax ID 508107997
- Bidder
- HIKMA FARMACÊUTICA (PORTUGAL) SA. · Tax ID 502266791
- Bidder
- LILLY PORTUGAL PRODUTOS FARMACÊUTICOS LDA · Tax ID 500165602
- Bidder
- PHARMIS BIOFARMACEUTICA · Tax ID 502595442
- Bidder
- Sanofi-Produtos Farmacêuticos · Tax ID 500134960
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €12,589.20
- Procedure base price
- €19,198.04
- Total effective price
- €12,558.00
- Publication date
- 12 March 2020
- Award date
- 8 March 2020
- Signing date
- 10 March 2020
- Performance period
- 291 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Hormonas e outros medicamentos usados no tratamento de doenças endócrinas
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4417294
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.